ストックスクリーナーアプリを入手
12.95
12.51%
1.44
アフターアワーズ：
13.01
0.06
+0.46%
前日終値:
$11.51
開ける：
$11.935
24時間の取引高:
1.22M
Relative Volume:
1.77
時価総額：
$852.29M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+19.69%
1か月 パフォーマンス:
+48.34%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$11.82
$13.12
1週間の範囲:
$10.81
$13.12
52週間の値動き範囲:
$5.33
$13.12
Niagen Bioscience Inc Stock (NAGE) Company Profile
NAGE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
12.95 | 852.29M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-27 | 開始されました | Canaccord Genuity | Buy |
| 2022-08-16 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-08-11 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | 開始されました | ROTH Capital | Buy |
| 2019-10-16 | 開始されました | Oppenheimer | Outperform |
| 2019-02-14 | 開始されました | B. Riley FBR | Buy |
| 2017-11-27 | 再開されました | H.C. Wainwright | Buy |
| 2017-09-25 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-01-03 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
Niagen Bioscience Inc (NAGE) 最新ニュース
Niagen Bioscience (NASDAQ:NAGE) Cut to "Buy" at Wall Street Zen - MarketBeat
Niagen Bioscience (NAGE) Receives Price Target Boost from Roth Capital | NAGE Stock News - GuruFocus
Niagen Bioscience (NASDAQ:NAGE) Price Target Raised to $23.00 - MarketBeat
What 4 Analyst Ratings Have To Say About Niagen Bioscience - Nasdaq
Niagen Bioscience (NASDAQ:NAGE) Shares Gap UpTime to Buy? - MarketBeat
Niagen Bioscience (NAGE) Target Price Raised to $23 by Roth Capi - GuruFocus
Niagen Bioscience Inc (NASDAQ:NAGE) Q1 2025 Earnings Call Transcript - MSN
Niagen Bioscience (NASDAQ:NAGE) Shares Up 8.2%Time to Buy? - MarketBeat
Niagen Bioscience to Present at Oppenheimer's 25th Annual Consum - GuruFocus
Niagen Bioscience to Present at Oppenheimer’s 25th Annual Consumer Growth and E-Commerce Conference - Business Wire
Niagen Bioscience (NASDAQ:NAGE) Reaches New 1-Year HighHere's Why - MarketBeat
Niagen Bioscience (NASDAQ:NAGE) Now Covered by Canaccord Genuity Group - MarketBeat
Niagen Bioscience (NASDAQ:NAGE) Coverage Initiated by Analysts at Canaccord Genuity Group - Defense World
Canaccord Genuity Initiates Coverage of Niagen Bioscience (NAGE) with Buy Recommendation - Nasdaq
Canaccord Genuity Initiates Niagen Bioscience at Buy With $13 Price Target - marketscreener.com
Canaccord starts Niagen Bioscience at Buy on ‘unique opportunity’ - TipRanks
Niagen Bioscience (NAGE) Receives Positive Outlook with $13 Pric - GuruFocus
Niagen Bioscience (NAGE) Receives Positive Outlook with $13 Price Target | NAGE Stock News - GuruFocus
Canaccord Analyst Recommends Buying Niagen Bioscience (NAGE) Stock | NAGE Stock News - GuruFocus
Niagen Bioscience: Overbought After Rally (NASDAQ:NAGE) - Seeking Alpha
3 Stocks That May Be Trading Below Their Estimated Value - simplywall.st
Niagen Bioscience (NASDAQ:NAGE) Reaches New 12-Month HighHere's Why - MarketBeat
Earnings Beat: Niagen Bioscience, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st
Niagen Bioscience Reaches Analyst Target Price - Nasdaq
Ratios Uncovered: Breaking Down Niagen Bioscience Inc (NAGE)’s Trailing Twelve Months Metrics - DWinneX
Niagen Bioscience: Q1 Earnings Snapshot - New Haven Register
Niagen Bioscience Inc (NAGE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook - BioSpace
Niagen Bioscience Reports Strong Q1 2025 Growth - TipRanks
Earnings call transcript: Niagen Bioscience Q1 2025 sales surge, stock rises - Investing.com Nigeria
Niagen Bioscience Inc (NAGE) Q1 2025 Earnings: EPS of $0.07 Beats Estimate, Revenue Surges to $30.5 Million - GuruFocus
Niagen Bioscience (NAGE) Reports Record Q1 Revenue with Strong G - GuruFocus
Niagen Bioscience (NAGE) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Niagen Bioscience Q1 2025 slides: revenue jumps 38%, raises full-year outlook - Investing.com
Niagen Bioscience, Inc. SEC 10-Q Report - TradingView
Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025 | NAGE Stock News - GuruFocus
What's Next: Niagen Bioscience's Earnings Preview - Nasdaq
Niagen Bioscience Inc expected to post earnings of 2 cents a shareEarnings Preview - TradingView
Niagen Bioscience (NAGE) Expands Clinical Network with New Clinics - GuruFocus
Niagen IV therapy expands to nearly 600 clinics nationwide By Investing.com - Investing.com India
Niagen IV therapy expands to nearly 600 clinics nationwide - Investing.com
Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide | NAGE Stock News - GuruFocus
Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide - Nasdaq
Three High Growth Companies Insiders Are Eager To Hold - Yahoo Finance
Niagen Bioscience Inc (NAGE) 財務データ
Niagen Bioscience Inc (NAGE) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.21%
1.51%
大文字化:
|
ボリューム (24 時間):